Core Insights - The wearable electronic blood pressure monitor market is experiencing explosive growth, driven by the increasing demand for health management solutions, particularly for hypertension, which has a rising prevalence in China [1][2][3] Group 1: Market Growth and Demand - The global medical-grade wearable device market is expanding at an annual growth rate of over 20%, expected to exceed 100 billion by 2030 [1] - The prevalence of hypertension in China is on the rise, with a patient awareness rate of only 51.6%, leading to a high mortality rate from hypertension-related diseases [1][2] Group 2: Product Innovation - Huawei's WATCH D2 represents a significant advancement in wearable blood pressure monitoring, featuring an integrated airbag system that enhances measurement accuracy and user comfort [2][3] - The WATCH D2 supports both single and dynamic blood pressure monitoring, allowing users to measure their blood pressure in various positions and situations throughout the day [3][4] Group 3: Regulatory and Clinical Validation - The WATCH D2 is the first wrist-worn dynamic blood pressure monitoring smartwatch to receive medical device registration from the Chinese National Medical Products Administration and CE MDR certification in the EU, along with seven global medical device certifications [4][6] - Clinical validation studies have confirmed the accuracy of the WATCH D2, comparing it with hospital-grade 24-hour blood pressure monitors [4][6] Group 4: Technological Advancements - The WATCH D2 utilizes oscillometric measurement methods combined with a micro airbag cuff, ensuring reliable and accurate blood pressure readings [6] - It is the first smartwatch capable of measuring blood pressure after high-intensity exercise, expanding the scenarios for accurate monitoring [6]

Core Insights - The conference focused on advancements in blood pressure monitoring, particularly highlighting the wearable wrist-based blood pressure measurement technology, with Huawei's WATCH D2 gaining significant recognition for its capabilities [2][3]. Industry Developments - Dynamic blood pressure monitoring (ABPM) is emerging as a new direction in the industry, crucial for early detection and effective management of hypertension, which is closely linked to cardiovascular diseases [3]. - Traditional monitoring methods are often difficult to popularize due to stringent conditions, while wrist-based dynamic blood pressure monitors can enhance user compliance due to their accuracy and comfort [3]. Company Innovations - Huawei aims to revolutionize blood pressure management through innovative technology, collaborating with professional institutions to provide precise and convenient health management solutions [5]. - The Huawei WATCH D2 features a medical-grade precision measurement capability, offering a new approach to blood pressure management [6]. - The device incorporates an innovative sensing system with a narrow mechanical cuff, achieving accurate measurements with a width of only 26.5mm, significantly enhancing comfort and accuracy [8]. - The WATCH D2 is the first wrist-based dynamic blood pressure monitor compliant with medical standards, capable of continuous monitoring throughout the day and night [8]. - It also supports blood pressure measurement after high-intensity exercise, helping users assess exercise intensity and identify potential cardiovascular risks [12]. Future Directions - Huawei's WATCH 5 introduces a new risk screening model for hypertension without the use of a cuff, utilizing a distributed sensing system for enhanced health monitoring [13][15]. - The X-TAP smart sensing window allows users to assess average blood pressure over 24 hours and provides health reports covering multiple health metrics [15][17]. - Huawei has been deeply involved in chronic disease management for ten years, collaborating with various authoritative institutions to advance blood pressure health research [17].